These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6734694)
1. Effect of oxprenolol and metoprolol on serum lipid concentration. Ferrara LA; Marotta T; Scilla A; Mastranzo P; Strazzullo P; Mancini M Eur J Clin Pharmacol; 1984; 26(3):331-4. PubMed ID: 6734694 [TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension. Tuomilehto J; Nissinen A Eur J Clin Pharmacol; 1979; 16(6):369-74. PubMed ID: 393518 [TBL] [Abstract][Full Text] [Related]
3. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients. Ravid M; Lang R; Jutrin I Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285 [TBL] [Abstract][Full Text] [Related]
4. Adrenergic mechanisms in control of plasma lipid concentrations. Day JL; Metcalfe J; Simpson CN Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension. Wilcox RG; Hampton JR Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103 [TBL] [Abstract][Full Text] [Related]
6. Effect of beta-blockers on plasma lipids. Pasotti C; Zoppi A; Capra A; Rebagliati M; Fogari R Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension. Comerford MB; Besterman EM Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874 [TBL] [Abstract][Full Text] [Related]
8. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia]. Pristautz H; Stradner F Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389 [TBL] [Abstract][Full Text] [Related]
9. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension]. Serro-Azul JB; Wajngarten M; Santomauro A; Braga A; Yazbek Júnior P; Bellotti G; Serro-Azul LG; Pileggi F Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113 [TBL] [Abstract][Full Text] [Related]
10. Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females. Szollár LG; Mészáros I; Tornóci L; Rischák K; Molnár M; Mányai S J Cardiovasc Pharmacol; 1990 Jun; 15(6):911-7. PubMed ID: 1694913 [TBL] [Abstract][Full Text] [Related]
11. The effect on HDL cholesterol of oxprenolol and atenolol. Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595 [TBL] [Abstract][Full Text] [Related]
12. The effect of captopril and metoprolol as monotherapy or combined with bendroflumethiazide on blood lipids. Foss OP; Jensen EK J Intern Med; 1990 Feb; 227(2):119-23. PubMed ID: 2405090 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. Thadani U; Davidson C; Singleton W; Taylor SH N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782 [TBL] [Abstract][Full Text] [Related]
14. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol. Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113 [TBL] [Abstract][Full Text] [Related]
15. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group. Zanchetti A Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. Antonaccio MJ; High J; DeForrest JM; Sybertz E J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238 [TBL] [Abstract][Full Text] [Related]
17. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial. Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174 [TBL] [Abstract][Full Text] [Related]
18. Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol. Ferrara LA; Mancini M; Marotta T; Pasanisi F; Fasano ML Eur J Clin Pharmacol; 1986; 29(6):717-9. PubMed ID: 3519237 [TBL] [Abstract][Full Text] [Related]
19. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism. Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656 [TBL] [Abstract][Full Text] [Related]
20. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients. Bell DS; Bakris GL; McGill JB Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]